Keyphrases
Human Platelets
100%
Heat Shock Protein 27 (HSP27)
58%
Phosphorylation
45%
Soluble CD40 Ligand
42%
Endothelial Glycocalyx
41%
Platelet Activation
37%
Collagen
35%
Platelet-derived Growth factor-BB (PDGF-BB)
32%
HSP27 Phosphorylation
31%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
30%
Syndecan-1
29%
Adenosine Diphosphate
27%
Mitogen-activated Protein Kinase
24%
Thromboxane A2 (TXA2)
23%
Platelet Aggregation
22%
Ligand Release
21%
Ristocetin
20%
Platelets
20%
Capillary
19%
Retrospective Cohort Study
19%
Glycocalyx
18%
Granule Secretion
18%
Adsorption
18%
Granulocytes
18%
Monocytes
18%
Apheresis
18%
Collagen-induced
18%
Rho Kinase
18%
Anticoagulant Therapy
16%
Generalized Pustular Psoriasis
14%
Antithrombin III (ATIII)
14%
Thrombin Receptor
14%
Lipopolysaccharide
13%
Osteoblast
13%
Critically Ill Patients
13%
Endotoxemia
12%
Experimental Endotoxemia
11%
Chemokine Ligand 12 (CXCL12)
11%
Platelet Granules
10%
Thrombomodulin
10%
Ultrastructure
10%
Major Trauma
9%
Trauma
9%
Acute Respiratory Distress Syndrome
9%
αB-crystallin
9%
Antiplatelet Therapy
9%
Amyloid Protein
9%
Epigallocatechin Gallate
9%
HSPB1
9%
Sepsis
9%
Pharmacology, Toxicology and Pharmaceutical Science
Heat Shock Protein 27
51%
CD40 Ligand
29%
Mitogen Activated Protein Kinase P38
29%
Syndecan 1
24%
Thromboxane A2
23%
Adenosine Diphosphate
23%
Ristocetin
20%
Injury
20%
Platelet Derived Growth Factor AB
19%
Rho Kinase
18%
Mitogen Activated Protein Kinase 1
16%
Anticoagulant Agent
11%
Adult Respiratory Distress Syndrome
10%
Lipopolysaccharide
10%
Experimental Endotoxemia
9%
Antithrombin III
9%
Sepsis
9%
Epigallocatechin Gallate
9%
Cohort Study
9%
Recombinant Thrombomodulin
9%
Thrombomodulin
9%
Glycoprotein Ib
9%
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
8%
Endothelium Injury
8%
Interleukin 6
7%
Endotoxemia
7%
Antiplatelet
7%
Disease
6%
Hemodialysis
6%
4 Amino 6 [2 [[4 (Diethylamino) 1 Methylbutyl]amino] 6 Methyl 4 Pyrimidinyl] 2 Methylquinoline
6%
Phosphotransferase
5%
Antithrombocytic Agent
5%
Pustular Psoriasis
5%
Multiple Organ Failure
5%
Non Insulin Dependent Diabetes Mellitus
5%
Polyphenol
5%
Diabetes Mellitus
5%
Biological Marker
5%
Medicine and Dentistry
Injury
26%
Retrospective Cohort Study
18%
Granulocyte
18%
Apheresis
18%
Anticoagulant Therapy
15%
Generalized Pustular Psoriasis
14%
Platelet
10%
Bleeding
9%
Amyloid Protein
9%
Syndecan 1
9%
Thrombin Receptor
9%
Antiplatelet
9%
Thrombocyte Activation
9%
Hemodiafiltration
8%
Computer Assisted Tomography
8%
Case Presentation
7%
Heat Shock Protein 27
6%
Lactic Acidosis
5%
Disease
5%
